GlaxoSmithKline Pharmaceuticals Ltd has announced the Audited Results for the quarter & year ended December 31, 2007:
The results for the quarter ended December 31, 2007
The Company has posted a net profit of Rs 809.00 million for the quarter ended December 31, 2007 where as the same was at Rs 677.90 million for the quarter ended December 31, 2006. Total Income is Rs 3679.40 million for the quarter ended December 31, 2007 where as the same was at Rs 3424.30 million for the quarter ended December 31, 2006.
The results for the year ended December 31, 2007
The Company has posted a net profit of Rs 5376.60 million for the year ended December 31, 2007 where as the same was at Rs 5455.10 million for the year ended December 31, 2006. Total Income is Rs 16669.80 million for the year ended December 31, 2007 where as the same was at Rs 16228.50 million for the year ended December 31, 2006.
The Consolidated Results are as follows:
The Audited Consolidated Results for the year ended December 31, 2007:
The Group has posted a net profit of Rs 5475.50 million for the year ended December 31, 2007 where as the same was at Rs 5510.00 million for the year ended December 31, 2006. Total Income is Rs 17010.80 million for the year ended December 31, 2007 where as the same was at Rs 16524.70 million for the year ended December 31, 2006.
The growth in Sales (excluding the Animal Health and Fine Chemicals businesses) was 7.8% and in Profit before Tax and Exceptional items was 13.8% for the year ended December 31, 2007 on a comparable basis. The growth in sales and profits was primarily driven by sales of priority products which registered a double digit growth, improvement in the gross margin and expense control. The figures for the current period are not comparable with those of the previous period, in view of the sale of the Fine Chemicals business on September 30, 2007 and of the Animal Health business on July 31, 2006.
The results for the quarter ended December 31, 2007
The Company has posted a net profit of Rs 809.00 million for the quarter ended December 31, 2007 where as the same was at Rs 677.90 million for the quarter ended December 31, 2006. Total Income is Rs 3679.40 million for the quarter ended December 31, 2007 where as the same was at Rs 3424.30 million for the quarter ended December 31, 2006.
The results for the year ended December 31, 2007
The Company has posted a net profit of Rs 5376.60 million for the year ended December 31, 2007 where as the same was at Rs 5455.10 million for the year ended December 31, 2006. Total Income is Rs 16669.80 million for the year ended December 31, 2007 where as the same was at Rs 16228.50 million for the year ended December 31, 2006.
The Consolidated Results are as follows:
The Audited Consolidated Results for the year ended December 31, 2007:
The Group has posted a net profit of Rs 5475.50 million for the year ended December 31, 2007 where as the same was at Rs 5510.00 million for the year ended December 31, 2006. Total Income is Rs 17010.80 million for the year ended December 31, 2007 where as the same was at Rs 16524.70 million for the year ended December 31, 2006.
The growth in Sales (excluding the Animal Health and Fine Chemicals businesses) was 7.8% and in Profit before Tax and Exceptional items was 13.8% for the year ended December 31, 2007 on a comparable basis. The growth in sales and profits was primarily driven by sales of priority products which registered a double digit growth, improvement in the gross margin and expense control. The figures for the current period are not comparable with those of the previous period, in view of the sale of the Fine Chemicals business on September 30, 2007 and of the Animal Health business on July 31, 2006.
No comments:
Post a Comment